Unusual Pharmacokinetic Behaviour

Unusual pharmacokinetic behaviour describes non-linear elimination, absorption saturation, or transporter involvement causing unpredictable exposure changes. Saturable metabolism at clinical doses produces non-linear kinetics. Active renal secretion supplements passive clearance. Enteric circulation prolongs elimination. Bioavailability variability exceeds prediction.

Population pharmacokinetic modelling characterises unusual kinetics. Therapeutic drug monitoring guides individual dosing. Regulatory submissions address unusual kinetics impact. Post-approval surveillance confirms kinetic predictions. Emerging analytics improve kinetic characterisation.